Stock Events

Stock Events

Indivior 

$30.59
0
-$1.07-3.38% Wednesday 04:00

Statistics

Day High
30.59
Day Low
30.59
52W High
-
52W Low
-
Volume
6
Avg. Volume
-
Mkt Cap
3.82B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 16
$0.1
Oct 15
$0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

23AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.22
0.42
0.62
0.82
Expected EPS
0.65
Actual EPS
N/A

Financials

16.95%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.48BRevenue
420MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INDV.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries manufactures generic drugs, including those for opioid addiction treatment, directly competing with Indivior's products.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its Janssen Pharmaceuticals division, offers products that compete in the opioid addiction treatment market.
Alkermes
ALKS
Mkt Cap5.07B
Alkermes plc provides addiction treatment products, including those for opioid dependence, which competes with Indivior's offerings.
DaVita
DVA
Mkt Cap8.4B
Dr. Reddy's Laboratories produces generic medication, including those for opioid addiction, competing with Indivior's Suboxone.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, through its Sandoz division, offers generic versions of drugs that compete with Indivior's addiction treatment products.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. has a portfolio of drugs that can be used in the treatment of addiction, potentially competing with Indivior's products.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. engages in the development of pharmaceuticals that could compete with Indivior's treatments for opioid dependence.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. has a diverse drug portfolio that could include treatments competing with Indivior's addiction therapy products.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company offers a range of pharmaceutical products that may compete with Indivior's opioid addiction treatments.

About

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Show more...
CEO
ISIN
GB00BN4HT335

Listings

BOATS
BOATS
INDV.BOATS
XNAS
US
INDV

0 Comments

Share your thoughts

FAQ

What is Indivior stock price today?▼
The current price of INDV.BOATS is $30.59 USD — it has decreased by -3.38% in the past 24 hours. Watch Indivior stock price performance more closely on the chart.
What is Indivior stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Indivior stocks are traded under the ticker INDV.BOATS.
What is Indivior market cap?▼
Today Indivior has the market capitalization of 3.82B
When is the next Indivior earnings date?▼
Indivior is going to release the next earnings report on April 23, 2026.
What were Indivior earnings last quarter?▼
INDV.BOATS earnings for the last quarter are 0.82 USD per share, whereas the estimation was 0.67 USD resulting in a +21.66% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Indivior revenue for the last year?▼
Indivior revenue for the last year amounts to 2.48B USD.
What is Indivior net income for the last year?▼
INDV.BOATS net income for the last year is 420M USD.
Does Indivior pay dividends?▼
Yes, INDV.BOATS dividends are paid annual. The last dividend per share was 0.1 USD. As of today, Dividend Yield (FWD)% is 0%.
When did Indivior complete a stock split?▼
Indivior has not had any recent stock splits.